Impact of renal impairment on the pharmacokinetic profile of intravenous difelikefalin, a kappa opioid receptor agonist for the treatment of pruritus
Authors
- Robert H. Spencer (ORCID: https://orcid.org/0000-0001-6435-9707)
- Thomas Marbury (ORCID: https://orcid.org/0000-0002-6416-3314)
- Patrick K. Noonan
- Frédérique Menzaghi (ORCID: https://orcid.org/0000-0002-3584-1665)
Institutions
- Orlando Clinical Research Center (US)
- Cara Therapeutics (United States) (US)
Funders
- Fresenius Medical Care North America